D. M. Kemp

Recombinant DNA Technology in Emerging Modalities for Melanoma Immunotherapy

O. Igoucheva, V. Alexeev, A. Pidich, 2013 .

Sporotrichoid-Like Spread of Cutaneous Mycobacterium chelonae in an Immunocompromised Patient

Y. Kauh, D. M. Kemp, A. Govind, 2017, Case reports in dermatological medicine.

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment

O. Igoucheva, Takami Sato, M. Terai, 2017, Oncotarget.

Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine

U. Rodeck, O. Igoucheva, V. Alexeev, 2013, Gene Therapy.

Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression.

Vitali Alexeev, Jouni Uitto, Jason B. Lee, 2017, The Journal of investigative dermatology.

Severe Airflow Obstruction in a Man with Stomatitis and Lymphadenopathy.

R. Summer, D. M. Kemp, Rachana Krishna, 2018, Annals of the American Thoracic Society.

Resolution of pre-cancerous and non-melanoma skin cancers after immune checkpoint inhibitor treatments.

Takami Sato, M. Mastrangelo, R. Weight, 2016 .